Ethics Review Contained

The most likely path is a contained Senate Ethics Committee review focused on whether staff disclosures were timely and compliant. Gillibrand's defense and the absence of a named enforcement action keep the matter politically damaging but not market-moving.

Each figure is the modeled move of the S&P 500 if the outcome occurs. For information only. Not investment advice.